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ABSTRACT
Bacteriophage Muin vitro transposition constitutes a
versatile tool in molecular biology, with applications
ranging from engineering of single genes or proteins
to modification of genome segments or entire gen-
omes. A new strategy was devised on the basis of
Mu transposition that via a few manipulation steps
simultaneously generates a nested set of gene con-
structions encoding deletion variants of proteins.
C-terminal deletions are produced using a mini-Mu
transposonthatcarriestranslationstopsignalsclose
to each transposon end. Similarly, N-terminal dele-
tions are generated using a transposon with appro-
priate restriction sites, which allows deletion of the
50-distal part of the gene. As a proof of principle, we
produced a set of plasmid constructions encoding
both C- and N-terminally truncated variants of yeast
Mso1p and mapped its Sec1p-interacting region. The
most important amino acids for the interaction in
Mso1p are located between residues T46 and N78,
with some weaker interactions possibly within the
region E79–N105. This general-purpose gene trunca-
tion strategy is highly efficient and produces, in a
single reaction series, a comprehensive repertoire of
gene constructions encoding protein deletion vari-
ants, valuable in many types of functional studies.
Importantly, the methodology is applicable to any
protein-encoding gene cloned in an appropriate
vector.
INTRODUCTION
DNA transposition-based methods have been used to modify
genes, genomes and proteins in both prokaryotic and euka-
ryotic organisms. While earlier applications utilized in vivo
transposition (1–3), a substantially simpliﬁed in vitro version
with puriﬁed components is currently available for several
transposons (4,5). The main advantage of using transposons in
genetic engineering applications is their ability to integrate
efﬁciently and relatively randomly into target DNA. However,
the efﬁciency and degree of integration randomness vary
considerably among different transposons (6). By performing
DNA transposition with a plasmid target in vitro, large pools
of insertion mutants can be produced in a single, simple
reaction series. Subsequent manipulation steps for a variety
of applications involve only standard molecular biology
techniques. Overall, a number of related strategies constitute
a multipurpose tool set for various types of molecular and
genomic studies (4,5).
One of the most versatile DNA transposition methods is an
in vitro system derived from bacteriophage Mu transposition
(7,8). The minimal Mu transposition reaction requires only a
simple reaction buffer and three puriﬁed macromolecular
components: transposon DNA, transposase protein MuA and
target DNA, the latter typically being a gene of interest cloned
in an appropriate plasmid. The Mu in vitro reaction is highly
efﬁcient with relatively low target site selectivity (8–10).
These properties make the Mu in vitro reaction ideal for
generating comprehensive libraries of mutant DNA molecules
foravarietyofmolecularbiologyapplications (11–17).Owing
to the malleability of Mu transposons, they can be modiﬁed to
contain any DNA between speciﬁc transposon ends. Typical
*To whom correspondence should be addressed. Tel: +358 9 19159516; Fax: +358 9 19159366. Email: harri.savilahti@helsinki.fi
Present address:
Jussi Ja ¨ntti, Program in Cellular Biotechnology, Institute of Biotechnology, Viikki Biocenter, PO Box 56, FI-00014, University of Helsinki, Finland
  The Author 2005. Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access
version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press
areattributedastheoriginalplaceofpublicationwiththecorrectcitationdetailsgiven;ifanarticleissubsequentlyreproducedordisseminatednotinitsentiretybut
only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oupjournals.org
Nucleic Acids Research, 2005, Vol. 33, No. 12 e104
doi:10.1093/nar/gni102constituents include selectable markers, reporter genes,
promoters, and in many cases a gene of interest (18).
Sets of protein deletion variants are commonly used to map
regions of functionality, particularly those involved in inter-
actions between two distinct proteins (19). Deletion plasmid
constructions encoding the protein of interest can be produced
by exonuclease digestion or restriction digestions; however,
exonuclease reactions are difﬁcult to control and restriction
enzymes are limited by the number of restriction sites in
the target DNA (20,21). Some strategies are based on PCR,
which is susceptible to errors during gene ampliﬁcation and
requires rational design for each deletion clone. In practice,
constructions need to be manufactured individually. Accord-
ingly, PCR-based techniques are laborious if the goal is to map
the region of interaction at reasonable resolution, particularly
in studies of large proteins. Thus, a technique that simultan-
eously and easily produces a library of deletion constructions
would be advantageous for the analysis of protein structure–
function relationships. In principle, emerging transposon-
based strategies should fulﬁll the demands, and progress
towards this end has been made recently by the use of Tn5
intramolecular transposition in vitro (22).
We tested whether the Mu in vitro transposition system
could be adapted to generate deletion constructions of protein
deletion variants. To test the performance of the strategy,
we prepared a library of deletion constructions using the
yeast Saccharomyces cerevisiae MSO1 gene as the target.
The encoded Mso1p is implicated in the transport and fusion
of vesicles destined for the plasma membrane (exocytosis) and
has previously been shown to physically interact with yeast
Sec1p (23). Sec1p is required for exocytosis (24,25); however,
its function in this process is still poorly understood, as is the
molecular basis of its interaction with Mso1p. To investigate
the interaction between Mso1p and Sec1p, several N- and
C-terminally truncated Mso1p deletion variants were analyzed
for their ability to interact with Sec1p. The results indicate that
the interacting region in Mso1p is located in the N-terminus,
primarily between residues T46 and N78 with possible inter-
actions in the region E79–N105. This study demonstrates that,
in a single reaction series, the strategy efﬁciently produces a
library of deletion variants that can be further utilized for
protein–protein interaction studies.
MATERIALS AND METHODS
Microbes, reagents and DNA techniques
Escherichia coli strains DH5a (Invitrogen) and BL21(DE3)
(26) were cultured in Luria broth (27) supplemented with
ampicillin (Ap, 100 mg/ml) and chloramphenicol (Cm,
10 mg/ml), when required. Yeast strain H2658 (MATa ura3-
52 leu2-3, 112 Dmso1::hphMX4; M. Knop, K.J. Miller,
M. Mazza, D. Feng, M. Weber, S. Kera ¨nen and J. Ja ¨ntti,
submitted) transformed with plasmid B578 [YEpSEC1aU,
(28)] lacks the MSO1 gene but overexpresses SEC1. Yeast
cultures were grown in synthetic complete medium lacking
uracil (29). MuA transposase was puriﬁed in collaboration
with Finnzymes (Espoo, Finland) as described (11,30).
Restriction enzymes (New England Biolabs) and T4 DNA
ligase (Promega) were used as recommended by the suppliers.
Complete Mini EDTA-free protease inhibitor cocktail tablets
and AEBSF (4-(2-aminoethyl)benzene sulfonyl ﬂuoride) were
from Roche. Imidazole was from Sigma and ProBond protein
puriﬁcation resin (Ni-NTA agarose) from Invitrogen. GelCode
Blue stain was from Pierce, Bradford protein assay reagents
from Bio-Rad, and ECL reagents from Amersham. Plasmid
DNA was prepared using plasmid DNA isolation kits from
Qiagen. Standard DNA techniques were performed as
described (27). DNA sequencing was performed with the
BigDye terminator cycle sequencing kit (Applied Biosystems)
and an ABI 377 XL sequencer (Applied Biosystems).
Plasmids and transposons
Plasmid pHis6-MSO1 (23) contains the 633 bp yeast MSO1
gene cloned in the SmaI site of pGAT-4 (31). This vector is
especially suitable for the gene truncation strategy: it carries,
50 from the multiple cloning site, a NotI site required to pro-
duce C-terminal fragments and a poly-His-encoding region for
easy puriﬁcation of the protein fragments. The two transpo-
sons used in this study (Figure 1) are derivatives of the cat-Mu
transposon (11) and were constructed using standard PCR and
cloning techniques (27). The cat-Mu(NotI) transposon has
been described previously (16). The cat-Mu(Stop) transposon
is similar to cat-Mu(NotI), but instead of NotI restriction sites
it contains three translation stop signals close to each trans-
poson end. Transposons were released from their respective
carrier plasmids by BglII digestion and puriﬁed by anion
exchange chromatography as described (11).
In vitro transposition reaction
The standard in vitro transposition reaction (25 ml) contained
180 ng transposon DNA as a donor, 500 ng plasmid
pHis6-MSO1 as a target, 0.22 mg MuA transposase, 25 mM
Tris–HCl, pH 8.0, 100 mg/ml BSA, 15% (w/v) glycerol,
Figure1.Comparisonbetweenwild-typeandmodifiedMuR-endsequencesof
thetwotransposonsusedinthisstudy.Thedepictedprecutconfigurationwitha
4n t5 0-overhang results from BglII digestion, which is used for transposon
isolation.Thearrowsindicatetheendmost30 nucleotides,andalteredbasepairs
are labeled with asterisks. The rectangles indicate the endmost MuA transpo-
sase binding sites.
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The reaction was carried out at 30 C for 4 h.
Generation of plasmid pools encoding Mso1p deletion
variants
N-terminal fragments. Ten in vitro transposition reactions
were performed otherwise as the standard reaction but con-
taining 720 ng transposon cat-Mu(Stop) donor and 0.88 mg
MuA transposase. The reactions were pooled, extracted with
phenol and subsequently with chloroform, ethanol precipit-
ated, and resuspended in 30 mlH 2O. Several aliquots (1 ml)
were electroporated (Bio-Rad Gene Pulser II with 25 mF
capacitance, 1.8 kV voltage and 200 W resistance, in 0.1 cm
cuvettes) into DH5a competent cells (25 ml) prepared as
described (32). Transposon-containing plasmid clones were
selected on LB-Ap-Cm plates. Approximately 1 · 10
5 colon-
ies were pooled and grown in LB-Ap-Cm medium at 37 C for
3 h. Plasmid DNA from the pool was isolated, digested with
XhoI and HindIII, and subjected to preparative electrophoresis
on a 0.8% SeaKemGTG (Cambrex) agarose gel in TAE buffer
(27). The 1.9 kb DNA fragment pool, corresponding to trans-
poson insertions into the MSO1 DNA fragment, was isolated
with the QIAquick Gel Extraction kit (Qiagen) and ligated
into the vector segment of pHis6-MSO1 digested with XhoI
and HindIII. The ligation mixture was electroporated into
DH5a cells, transposon-containing clones were selected on
LB-Ap-Cm plates, and plasmid DNA was prepared from
 1 · 10
4 colonies.
C-terminal fragments. Six standard in vitro transposition
reactions, with cat-Mu(NotI) as a donor, were pooled, extrac-
ted with phenol and subsequently with chloroform, ethanol
precipitated, and resuspended in 20 ml water. Electroporation
was carried outasabove, and plasmidDNAwaspreparedfrom
a pool of  6 · 10
5 colonies. MSO1 fragments that carried
transposon insertions were cloned into a clean vector back-
bone as described above, and  5 · 10
4 colonies were pooled.
Most ofthetransposon DNA andthe 50-distal part oftheMSO1
gene were then excised from the plasmid pool by a cleavage
with NotI, followed by isolation of the plasmid backbone by
preparative electrophoresis as above and recircularization
by ligation at low DNA concentration ( 1 ng/ml). Ligated
plasmids were electroporated into DH5a cells as above and
selected on LB-Ap plates. The ﬁnal C-terminal deletion
mutant plasmid library contained  3 · 10
4 colonies.
Verification of deletion clones and protein expression
Individual deletion plasmid clones were subjected to restric-
tion analysis (Figure 3A and B) with BamHI (N-terminal
fragments) or NotI and HindIII (C-terminal fragments), and
the deletion joint sequences were determined by sequencing
(Figure 3C). For protein expression, individual plasmid
clones (Figure 4A) were introduced into the E.coli strain
BL21(DE3). Cells were grown in LB-Ap medium at 37 Ct o
an OD600 of 0.5, and Mso1p expression was induced for 3 h by
the addition of 1 mM IPTG (Fermentas).
Purification of the Mso1p deletion variants
A cell pellet from a 50ml culture was resuspended in3 ml urea
buffer (100 mM NaH2PO4, 10 mM Tris–HCl and 8 M urea,
pH 6.3) containing Complete Mini EDTA-free protease inhib-
itorcocktailtablets (2tablets per10mlbuffer)andlysedon ice
by sonication with an MSE Soniprep 150 ultrasonic homogen-
izer (eight times for 20 s with 30 s intervals). Cell debris was
removed by centrifugation at 10 000 g for 10 min. The super-
natant wasmixedwith 200 mlof ProBond resin,and the Mso1p
was allowed to bind at 4 C for 1 h. The resin was collected by
centrifugation at 600 g for 3 min at 4 C, washed twice with
10 ml urea buffer, twice with 10 ml imidazole buffer [50 mM
NaH2PO4, 300 mM NaCl, 20 mM imidazole and 0.05% (v/v)
Tween-20, pH 8.0], and once with 10 ml buffer A [100 mM
NaH2PO4, 500 mM NaCl and 10% (v/v) glycerol, pH 6.0]. All
washes were performed by gently rotating the tubes at 4 C for
10 min. Each resin-bound Mso1p variant was stored in buffer
Aa t4  C as a 50% slurry. Following boiling in sample buffer
(27), the protein content of these preparations was analyzed on
15% SDS–PAGE gels stained with GelCode Blue (Figure 4B).
Binding assay
The interaction of Sec1p with Mso1p variants was analyzed
using a Sec1p pull-down assay. Initially, a lysate was prepared
from the yeast strain H2658+B578 as follows. Cells were
grown in a 600 ml culture to OD600 of 1.5, harvested by
centrifugation and resuspended in 6 ml MOPS lysis buffer
(40 mM MOPS, pH 6.8, 100 mM NaCl, 4 mM AEBSF and
10 mM NaN3) containing protease inhibitors (1 cocktail tablet
per 25 ml buffer). Cells were broken with a Bead Beater
(Biospec Products) and zirconia/silica beads using six consec-
utive 45 s treatments at 4 C with 1 min intervals on ice. Triton
X-100 (10%, v/v) was added to a ﬁnal concentration of 1%,
and the suspension was incubated on ice for 30 min. The cell
debris was removed by centrifugation, and the total protein
concentration was determined using the Bradford assay.
Resin-bound Mso1p variants (described above; equivalent
to  30 mg of Mso1p) were incubated for 1 h at 4 C with the
yeast lysate (6 mg total protein) supplemented with 80 mM
imidazole. The resin was washed three times for 20 min with
MOPS lysis buffer supplemented with 1% Triton X-100 and
80 mM imidazole, and ﬁnally rinsed with the same buffer
lacking imidazole. The proteins were separated using 10%
SDS–PAGE and transferred onto nitrocellulose ﬁlters that
were then incubated with a polyclonal antibody (1:3000
dilution) against Sec1p (23). Immunoreactive bands indicating
Mso1p–Sec1p interaction were detected with the ECL system
using Kodak MR-1 ﬁlm.
RESULTS
Experimental outline
We developed a Mu in vitro transposition-based strategy that
generates a series of protein deletion variants. To illustrate the
method, we used the yeast MSO1 gene as a target for deletion
mutagenesis and subsequently deﬁned the region in Mso1p
that interacts with Sec1p. Two deletion mutant libraries
were produced, one encoding N-terminal fragments and the
other encoding C-terminal fragments of Mso1p. This was
accomplished by using custom-designed artiﬁcial transposons
cat-Mu(Stop) and cat-Mu(NotI), respectively. These two
transposons are derivatives of the cat-Mu minitransposon
(8,11) and contain deﬁned modiﬁcations within the Mu R-end
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stop codons near each transposon terminus, and cat-Mu(NotI)
contains a NotI site close to each transposon end. As a
selectable marker, these transposons employ the commonly
used chloramphenicol acetyl transferase (cat) gene.
The reaction series for the generation of the two libraries
followed similar outlines (Figure 2). Initially, the plasmid
containing the MSO1 gene was used as a target in an
in vitro transposition reaction with the modiﬁed mini-Mu
transposon as a donor. The resulting plasmids were pooled,
and the transposon-containing MSO1 from each pool was then
subcloned into a ‘clean’ plasmid backbone to limit the trans-
poson insertion sites to those within the MSO1 region
(Figure 2A). At this stage, the constructions for N-terminal
fragments were ready for screening and protein expression
(Figure 2B). Before screening, the constructions encoding
C-terminal fragments were further modiﬁed by NotI digestion
and plasmid recircularization by ligation, thus eliminating the
transposon core together with the 50-distal coding region of
MSO1 (Figure 2C).
Generation of plasmid pools encoding truncated
Mso1p variants
Our gene truncation strategy using MSO1 as a target yielded
 1 · 10
4 and  3 · 10
4 clones for the libraries encoding
N-terminal and C-terminal protein variants, respectively.
Fifteen randomly selected clones from each library were sub-
jected to restriction analysis (Figure 3A and B), in which a
variation in length ofa particularrestrictionfragmentindicates
a successfully generated deletion series. Indeed, such variab-
ility was observed, suggesting that each clone represented a
unique deletion variant. A number of deletion clones (poten-
tially encoding 23 N-terminal fragments and 45 C-terminal
fragments) were then ﬁne-mapped by DNA sequencing to
identify the exact location of their respective deletion joints.
Among the clones mapped, we detected 20 unique deletion
joint positions for N-terminal fragments and 35 for C-terminal
fragments. Their distribution along the MSO1 gene is shown
in Figure 3C. Among the 68 clones analyzed, we identiﬁed
46 insertion sites once, 8 sites twice and 2 sites three times,
evidentlyreﬂectingtherelativelyweaktargetsiteselectivityof
Mu transposition. All of the sequenced clones contained fault-
less deletion joint sequences, indicating a high degree of
accuracy during the manipulation steps. All the clones encod-
ing N-terminal Mso1p variants were useful for protein expres-
sion, as the engineered stop codons terminated Mso1p
translation in all three reading frames. Theoretically, however,
for MSO1 50-distal deletions, a proper reading frame is expec-
ted to be retained in one out of three clones, implying that only
one-third of the clones encode a useful C-terminal protein
variant (see Discussion). In our collection of the 50-distal dele-
tion clones, 12 of 45 (27%) retained a proper reading frame for
the expression of Mso1p variants, in reasonable agreement
with the 33% theoretical yield.
Mso1p–Sec1p binding assay
For the Sec1p binding assay, we puriﬁed a representative set of
Mso1p deletion variants (Table 1 and Figure 4A) using metal
afﬁnity chromatography, as all of the protein fragments con-
tained a His tag at the N-terminus. Using the same standard
Figure 2. (A) Common initial steps of constructing a transposon insertion
library for a gene of interest [(39), this study]. (B and C) Additional steps
of constructing the deletion mutant libraries of N- and C-terminal protein
fragments with cat-Mu(Stop) and cat-Mu(NotI) transposons, respectively.
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type protein as well as seven N-terminal and ﬁve C-terminal
Mso1p fragments. We obtained a good quality preparation of
each protein variant, as veriﬁed by SDS–PAGE (Figure 4B).
Finally, to locate the Sec1p-interacting region in Mso1p, we
analyzed the ability of the Mso1p deletion fragments to bind
Sec1p. The His-tagged Mso1p fragments were bound to
Ni-NTA agarose resin via their His tags, and the resin was
incubatedwith soluble fraction ofyeastlysate containingover-
expressed Sec1p. The resin was collected, washed and the
presence or absence of Sec1p bound to Mso1p fragments
was analyzed by immunoblotting using an antiserum to
Sec1p (Figure 4C). Most of the N-terminal Mso1p fragments,
including the fragment containing amino acids 1–78, bound
Sec1p efﬁciently; and only the shortest fragment (1–46) failed
to bind. Two of the longest C-terminal fragments (9–210 and
35–210) also bound Sec1 efﬁciently. The fragment 78–210
bound less efﬁciently than the wild-type protein, and binding
was abolished upon further deletion from the N-terminus (i.e.
fragments 105–210 and 136–210). These results indicate that
the most critical region for Sec1p binding lies between resi-
dues 46 and 78 in Mso1p and that there probably are some
weaker interactions within the region E79–N105; however,
the latter interactions are not necessary for efﬁcient Sec1p
binding given that fragment 1–78 bound Sec1p equivalently
to wild-type Mso1p.
DISCUSSION
A new strategy to produce pools of plasmids encoding N- and
C-terminal deletion variants of proteins is presented in this
paper. The methodology is based on the in vitro transposition
of phage Mu. We produced deletion variants of the yeast
MSO1 gene and mapped the region in Mso1p that interacts
with yeast Sec1p.
The Mu in vitro transposition system is highly efﬁcient,
easily producing sizeable insertion mutant libraries of target
plasmids (8). Due to easy selection of integrants by the use of
appropriate antibiotics, 100% of the selected plasmid clones
contain a transposon insertion. Owing to the symmetric nature
of the transposon ends, all these plasmids are appropriate for
further manipulation steps irrespective of the relative orienta-
tion of the inserted transposon. Importantly, in addition to a
5 bp target site duplication, mini-Mu insertions do not induce
other rearrangements, such as deletions or nonpredictable base
pair additions, at the site of integration [(8,16), this study].
Mini-Mu transposons utilized in in vitro reactions can carry
essentially any DNA between the short Mu-speciﬁc ends (8).
This DNA typically contains selectable genes or other con-
venient genetic markers. The transposon ends, including the
sequences required for initial transposase binding and sub-
sequent transpososome assembly, also tolerate some sequence
variation (16). In this study, we utilized a transposon that
carries three translation stop signals close to each terminus;
and similarly, a second transposon variant that contains an
engineered NotI site at each end. Despite these modiﬁcations,
Figure 3. Analysis of individual deletion constructions at the DNA level.
Individual plasmid clones were isolated for the analysis. Details of generating
the N- and C-terminal fragments are shown on the left and right, respectively.
(A)Deletionconstructions.ThetargetplasmidcontainstheMSO1geneinserted
into the SmaI site of pGAT-4. The transposon is shown in black (transposon
ends as thick lines) within the protein coding region (thick grey line). For
C-terminal fragments, the construction is shown before and after the excision
of the transposon and the 50-coding region with NotI digestion and religation.
(B) A random set of plasmids analyzed to demonstrate the variability of the
insertion sites. Fifteen constructions for N-terminal fragments were digested
with BamHI. A diagnostic fragment (0–650 bp) is produced depending on the
transposon insertion site. Also, 15 plasmid clones encoding C-terminal frag-
mentsweredigestedwithNotIandHindIII;adiagnosticfragmentis50–700bp
in length.Sampleswere run in a 2% MetaPhor agarosegel at 70V for110 min.
(C) The distributionof transposoninsertion sites in randomly selected samples
asdeterminedbyDNAsequencing.TheMSO1wtsequenceisdepictedasaline
from 0 to 633 bp, and the insertion sites are indicated (23 N- and 45 C-terminal
constructions).
Table 1. Details of the selected deletion mutants verified by DNA sequencing
Amino
acids
Size
(kDa)
Sequence Extra
amino acids
Sec1p-
binding
N-terminal 1–194 26 —ASSGVID* 2 +
fragments 1–158 22 —RPTRWID* 3 +
1–146 20 —HTSSSSD* 1 +
1–131 18 —PEYTPAS*0 +
1–96 15 —KQNSLID* 3 +
1–78 13 —KEDLPND* 1 +
1–46 9 —GDTVNTD* 1  
C-terminal 9–210 25 *QEGSGR—0 +
fragments 35–210 22 *IKAEKD—0 +
78–210 17 *NERKIL—0 –
105–210 14 *NRRKAS—0  
136–210 11 *DIYNNH—0  
In the set of N-terminalfragments,there canbe up to three extraamino acids at
theC-termini,dependingonwhichstopcodoninthetransposonendmatchesthe
reading frame of the encoded protein. The bolded sequences correspond to
Mso1p, and extra C-terminal amino acids are shown in regular font. The pre-
dicted size of each fragmentincludes the N-terminal His6 tag. Asterisks denote
theproteintermini.TheresultofSec1pbindingassayisdenotedas + (binding),
 (no binding), – (intermediate binding).
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integrant plasmid clones, although with lower efﬁciency as
compared with the corresponding wild-type transposon. In a
direct comparison experiment (standard reaction conditions,
4 h incubation time), cat-Mu(Stop) and cat-Mu(NotI) yielded
integrant clones with roughly 10 and 70% efﬁciency of the
wild-type transposon (cat-Mu), respectively (data not shown).
Even with these efﬁciencies, the number of integrant clones
obtained in standard reaction conditions should easily be far
greater than the potential number of unique deletion variants
for a standard size protein. For more demanding projects, the
efﬁciency can further be increased by addition of more
transposon DNA and MuA transposase in the reaction. For
example, with cat-Mu(Stop) we used four times (4·) higher
concentrations of these reaction components. The number of
integrant clones obtained in these conditions approaches the
level of that obtained with the wild-type cat-Mu transposon in
standard (1·) reaction conditions (data not shown).
We constructed a new transposon, cat-Mu(Stop), which
carries translation stop signals in all three reading frames,
thereby terminating translation near the transposon insertion
site (Figure 1). This transposon can generate a library of gene
constructions encoding C-terminally truncated protein vari-
ants, given that the gene of interest is cloned in an appropriate
plasmid. We designed the stop codons to reside as close as
possible to the transposon ends, and most of the modiﬁed
nucleotides do not overlap with the critical transposase bind-
ing site (Figure 1). All of the C-terminally truncated deletion
variants will be translated from the common initiation codon,
and the transposon insertion site will dictate which stop codon
is used for each individual clone. Some clones will directly
terminatetranslationwithouttheadditionofextra aminoacids.
However, the rest of the clones will encode one to three addi-
tional amino acids at the C-terminus of each fragment. The
exact composition of the encoded amino acids is dependent on
the original sequence. Such short additions will be tolerated
for most applications and would not be expected to signiﬁc-
antly affect the biological function of the fragment, particu-
larly in comparison with the effect of the deletion itself.
We used the cat-Mu(NotI) transposon (16) to produce con-
structions encoding N-terminally truncated protein variants.
This strategy requires that the vector contains a suitably loc-
ated unique NotI restriction site 50 from the cloned target gene.
By NotI digestion of plasmids, each carrying a transposon
insertion in the target gene, the 50-distal part of the gene
and the transposon core is eliminated. Since the original trans-
lation start signal is retained in each clone, the resulting
protein variants are truncated at their N-termini. An apparent
drawback of the strategy is that only one-third of the clones
will encode a C-terminal protein fragment in a proper reading
frame with the start codon, depending on the number of base
pairs deleted. However, due to high efﬁciency of the strategy,
this does not limit the number of different deletion variants
generated; but for further analyses, suitable clones should be
selected by an appropriate initial screening.
The described deletion mutagenesis strategy does not
require specially engineered vectors, although certain aspects
need to be considered carefully. The vector must be of sufﬁ-
cient size for the adequate electrophoretic separation of the
vector backbone from the pool of fragments representing
transposon insertions into the target gene (Figure 2). For
the generation of C-terminal fragments, the vector must con-
tain a unique NotI restriction site between the translation start
signal and the beginning of the actual coding sequence of the
targetgene.Complementarily,thetargetgenemustnotcontain
NotI sites. This typically is of little concern, as NotI is a rare-
cutting enzyme with 8 nt recognition sequence. For isolation
of Mso1p variants, we used a vector that encodes an additional
His6 tag at the N-terminus of each expressed protein. This
feature is not mandatory for the strategy but constitutes a
means for convenient protein puriﬁcation.
Mu inserts into a broad spectrum of target sites in DNA
(9,10,16). With the described strategy, it is possible to produce
extensive libraries of deletion constructions containing the
majority of all potential variants. We aimed at producing a
saturating library of a minimum of 10
4 clones that would
represent a broad diversity of insertions; theoretically, every
possible insertion site becomes targeted several times in a
library of this magnitude. However, the spectrum of different
mutant clones is to a certain degree inﬂuenced by the target
gene sequence (10). Individual clones can be screened by
Figure 4. Analysis of Mso1p–Sec1p interaction. (A) Graph illustrating the
Mso1p part of the different deletion variants and their Sec1p-binding charac-
teristics. Number ranges indicate the Mso1p residues contained in the frag-
ments. The grey rectangle depicts the binding region. (B) Analysis of purified
Mso1p deletion variants by SDS–PAGE. (C) Mso1p–Sec1p binding analysis.
Mso1p fragments that were bound to agarose beads were incubated with yeast
lysate containing overexpressed Sec1p. The proteins were resolved by 10%
SDS–PAGE,transferredtonitrocellulosefilters,andthepresenceofSec1pwas
detected with a polyclonal antiserum and ECL reagents. The fragment order is
the same as in (B). Controls: ( ) yeast lysate not overexpressing Sec1p; (+)
yeast lysate overexpressing Sec1p; (0) a sample with no Mso1p added as a
negative control.
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different deletion plasmids to map protein interaction regions
at high precision.
We chose a small set of Mso1p deletion constructions for
protein puriﬁcation and Sec1p binding assays. The results
indicate that within Mso1p, the most important amino acids
for the Sec1p interaction are located between residues 46 and
78. The region between 79 and 105 probably is involved in the
interaction as well, but this region is not essential for binding.
Previous Mso1p–Sec1p interaction studies showed that the
C-terminal part of Mso1p is not necessary for the Sec1p inter-
action; a deletion protein containing the 164 N-terminal amino
acids of Mso1p bound Sec1p in a yeast two-hybrid assay (23).
The current ﬁndings expand on the knowledge of Mso1p–
Sec1p interaction, and they are in full agreement with yeast
two-hybrid results and other in vivo analyses of functionally
important domains of Mso1p (M. Knop, K.J. Miller,
M. Mazza, D. Feng, M. Weber, S. Kera ¨nen and J. Ja ¨ntti,
submitted).
Previous methods for deletion mutagenesis of proteins
include partial exonuclease digestions or restriction enzyme
cleavages of DNA constructions (20,33). However, exonuc-
lease digestions can be difﬁcult to control, and restriction
enzyme cleavages are limited to the existing sites within
the gene. Accordingly, these strategies are not convenient for
ﬁne mapping of speciﬁc regions in proteins. Intramolecular
transposition-based procedures for producing deletion variants
of plasmids have been described for transposon Tn9 and mem-
bers of the Tn3 and Tn5 families (22,34–36). However, most
of these methods suffer from low frequency of transposition
and low overall efﬁciency of producing deletions. Until now,
the Tn5 in vitro system probably represents the most efﬁcient
transposition-based method for the purpose of generating
protein deletion variants (22). While useful, the strategy has
certain drawbacks, however. It requires a special vector for
intramolecular transposition, and <70%of theproduced clones
are true deletion constructions. In addition, the published pro-
tocol includes a description for the generation of C-terminally
truncated protein variants only, although the possibility
of using a similar strategy for N-terminally truncated variants
is being discussed (22). For comparison, the Mu transposition-
based strategy described in this paper can utilize a wider
selection of vectors and all the plasmid clones obtained are
genuine deletion constructions. In addition, both N- and
C-terminally truncated protein variants can be produced
with relative ease by the use of similar procedures.
Nested sets of deletions are useful for studies of relation-
ships between sequence, structure and function. Most often
they are used to deﬁne regions involved in protein–protein
interactions between protein monomers in homomultimers
or between separate proteins. They are also used to specify
regions that are required for different functions. One useful
application for deletion libraries is protein fragmentation,
i.e. dissection of proteins into distinct subdomains to identify
independently folding units that interact non-covalently to
form a functional protein (37). Furthermore, deletion libraries
can be used to minimize proteins into fragments when
developing drugs for the purpose of disrupting interactions
at protein–protein interfaces (38). Finally, by screening dele-
tion libraries,it isalso possible toidentifyproteinswith altered
properties.
The strategy described in this study is rapid and efﬁcient,
and it constitutes an economical way of producing a large
number of protein deletion derivatives. The inherent accuracy
of Mu in vitro transposition, in combination with effective
selection schemes during DNA manipulation steps, guarantees
high quality protein-expressing gene truncation libraries.
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